cephalexin has been researched along with meropenem in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
De Luca, F; Delmarcelle, M; Docquier, JD; Dubus, A; Frère, JM; Nacoulma, OG; Rossolini, GM; Simporé, J; Zeba, B | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kitamura, Y; Suzuki, R; Tateno, Y | 1 |
Das, CK; Nair, NN | 1 |
Bajčetić, M; Božić, B; Korać, J; Popović-Bijelić, A; Pristov, JB; Romanović, M; Spasić, S; Spasojević, I; Stanić, M; Stanković, DM | 1 |
Doogue, M; Jensen, BP; Mortensen, JS | 1 |
2 review(s) available for cephalexin and meropenem
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Preanalytical Stability of Flucloxacillin, Piperacillin, Tazobactam, Meropenem, Cefalexin, Cefazolin, and Ceftazidime in Therapeutic Drug Monitoring: A Structured Review.
Topics: Anti-Bacterial Agents; Cefazolin; Ceftazidime; Cephalexin; Drug Monitoring; Drug Stability; Floxacillin; Humans; Meropenem; Piperacillin; Tazobactam | 2022 |
7 other study(ies) available for cephalexin and meropenem
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.
Topics: Adult; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalexin; Cephalosporins; Cephalothin; Chryseobacterium; Female; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Protein Structure, Secondary; Sequence Homology, Amino Acid | 2009 |
Previously undiagnosed hereditary spherocytosis in a patient with jaundice and pyelonephritis: a case report.
Topics: Abdominal Cavity; Adult; Anti-Bacterial Agents; Cephalexin; Female; Humans; Jaundice; Meropenem; Osmotic Fragility; Pyelonephritis; Radiographic Image Enhancement; Spherocytosis, Hereditary; Splenomegaly; Thienamycins; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Hydrolysis of cephalexin and meropenem by New Delhi metallo-β-lactamase: the substrate protonation mechanism is drug dependent.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Binding Sites; Biocatalysis; Catalytic Domain; Cephalexin; Hydrolysis; Kinetics; Meropenem; Molecular Dynamics Simulation; Quantum Theory; Thermodynamics; Thienamycins; Water | 2017 |
Coordination and redox interactions of β-lactam antibiotics with Cu
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cefaclor; Ceftazidime; Ceftriaxone; Cephalexin; Coordination Complexes; Copper; Escherichia coli; Meropenem; Microbial Sensitivity Tests; Oxidation-Reduction; Penicillin G; Solubility; Staphylococcus aureus | 2018 |